Indivior Pharmaceuticals, Inc. - 8-K Filing
Indivior Pharmaceuticals agreed to acquire Supernus Pharmaceuticals for $1.5401 per Indivior share, with a special dividend of $1B funded via a $650M loan. (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $INDV